Study Of An Investigational Drug For Non-Relapsing Secondary Progressive Multiple Sclerosis
Seeking men and women aged 18-60 for a study of an investigational drug for non-relapsing secondary progressive multiple sclerosis.
Seeking men and women aged 18-60 for a study of an investigational drug for non-relapsing secondary progressive multiple sclerosis.
Seeking adult men and women with HER2 positive breast cancer who have already received treatment to determine if a combination of different drugs is better than the usual treatment alone in preventing this cancer from returning.
Seeking men and women with HER2-positive breast cancer for a study comparing the usual multi-drug chemotherapy to a single chemotherapy drug and HER-2 therapy.
Seeking men and women with hormone receptor positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced inoperable or metastatic breast cancer for a study of an investigational drug combination.